Differential regulation of alpha7 nicotinic receptor gene (CHRNA7) expression in schizophrenic smokers.
about
Cotinine: Beyond that Expected, More than a Biomarker of Tobacco Consumption.Genetics of schizophrenia and smoking: an approach to studying their comorbidity based on epidemiological findingsThe chimeric gene CHRFAM7A, a partial duplication of the CHRNA7 gene, is a dominant negative regulator of α7*nAChR functionThe human CHRNA7 and CHRFAM7A genes: A review of the genetics, regulation, and functionTargeting Prefrontal Cortical Systems for Drug Development: Potential Therapies for Cognitive DisordersMapping asthma-associated variants in admixed populationsNicotinic α7 receptors enhance NMDA cognitive circuits in dorsolateral prefrontal cortexnAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives.Neuronal effects of nicotine during auditory selective attention in schizophreniaChronic nicotine improves short-term memory selectively in a G72 mouse model of schizophrenia.Patterns of deficits in brain function in bipolar disorder and schizophrenia: a cluster analytic study.Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophreniaNeurobiological background of negative symptoms.Theranostic Biomarkers for SchizophreniaAlexa Fluor 546-ArIB[V11L;V16A] is a potent ligand for selectively labeling alpha 7 nicotinic acetylcholine receptorsAdmixture mapping of lung cancer in 1812 African-Americans15q11.2-13.3 chromatin analysis reveals epigenetic regulation of CHRNA7 with deficiencies in Rett and autism brain.Transcriptional repression of the α7 nicotinic acetylcholine receptor subunit gene (CHRNA7) by activating protein-2α (AP-2α).Alpha7 nicotinic acetylcholine receptors modulate motivation to self-administer nicotine: implications for smoking and schizophrenia.Nicotinic receptor contributions to smoking: insights from human studies and animal modelsEarly developmental elevations of brain kynurenic acid impair cognitive flexibility in adults: reversal with galantamineA randomized exploratory trial of an α-7 nicotinic receptor agonist (TC-5619) for cognitive enhancement in schizophrenia.Acute nicotine improves social decision-making in non-smoking but not in smoking schizophrenia patientsNicotine induces the up-regulation of the α7-nicotinic receptor (α7-nAChR) in human squamous cell lung cancer cells via the Sp1/GATA protein pathway.The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders.Altered gene expression in the dorsolateral prefrontal cortex of individuals with schizophrenia.A review of neurobiological vulnerability factors and treatment implications for comorbid tobacco dependence in schizophrenia.Going up in smoke? A review of nAChRs-based treatment strategies for improving cognition in schizophrenia.Diverse strategies targeting α7 homomeric and α6β2* heteromeric nicotinic acetylcholine receptors for smoking cessation.Translating advances in the molecular basis of schizophrenia into novel cognitive treatment strategies.Targeting neuronal dysfunction in schizophrenia with nicotine: Evidence from neurophysiology to neuroimaging.Genetic knockout of the α7 nicotinic acetylcholine receptor gene alters hippocampal long-term potentiation in a background strain-dependent manner.Cortical kynurenic acid bi-directionally modulates prefrontal glutamate levels as assessed by microdialysis and rapid electrochemistry.Prevalence, correlates of, and reasons for using roll-your-own tobacco in a high RYO use country: findings from the ITC New Zealand survey.Hippocampal α7 nicotinic acetylcholine receptor levels in patients with schizophrenia, bipolar disorder, or major depressive disorder.Initial Cross-Over Test of a Positive Allosteric Modulator of Alpha-7 Nicotinic Receptors to Aid Cessation in Smokers with or Without Schizophrenia.Effect of alpha7 nicotinic acetylcholine receptor agonists on attentional set-shifting impairment in rats.Nicotinic modulation of salience network connectivity and centrality in schizophrenia.Modulation of auditory deviance detection by acute nicotine is baseline and deviant dependent in healthy nonsmokers: a mismatch negativity study.Nicotinic acetylcholine receptor expression on B-lymphoblasts of healthy versus schizophrenic subjects stratified for smoking: [3H]-nicotine binding is decreased in schizophrenia and correlates with negative symptoms.
P2860
Q21129280-AFBAB23D-66AA-40D0-9E7D-CD2D73B89140Q24289498-D0C352DA-2FF0-493F-AF60-A9D27C778194Q24308763-F1BDEFA4-6D4C-44B1-BDE1-8E6A2CD563FCQ26821785-6A597950-3FDE-4EEE-AB2E-4F1D95F366DAQ28076907-F4D62536-7FB3-4F71-991E-E24E7563D17CQ28087013-C016D95C-B70F-4515-8409-124FF9016D63Q28293779-306D71C6-6B2B-4DB2-84F0-84ACB09483F9Q30362464-570EA12D-7E3A-414F-AA84-7CBC055F526FQ30366764-4B760C6C-34E6-4598-BA31-ADDDFE206FC4Q30415168-AB9D7F96-D7ED-4B77-9716-DB84A1D8539AQ30445337-0F0638DC-2587-4CCA-A835-729B551BD6E8Q30459624-CEF7F0AC-9244-4B83-B94E-C9D8C3FF4257Q30913824-E14A3A56-CBD4-4DD7-9E6D-55F749429E01Q33624412-1D94B0D8-AC8A-44E4-AA74-CFA5B44C4458Q34113842-13180A59-D0E3-47FD-98D7-90F1E109A166Q34617222-1E16F89A-6E4A-42D6-88DC-574B46B4F48EQ35389369-37FB08EE-B49D-4ADE-92F0-F8A7B19B8F80Q35604900-09F011BB-FE2A-44CE-BD87-D05023866F63Q35837691-E24751BD-F088-4E08-84D8-836099B3AB74Q35966896-06C76AAE-68E0-4638-B9C5-1F4E7B3BCA3EQ36755954-4E2C4BFA-543B-4767-B904-753916120FB1Q36775219-D1B5B7A2-D97C-4BFD-8FE5-5775D922DAF8Q37267275-1B3311F1-8CFE-41E4-8663-CEB819CEF0EDQ37311353-05333DD8-D812-46F9-8B22-9126195CD5B8Q37318862-6C004427-B16C-4F82-95D0-DD00C6E328FBQ37663262-DAC1D1B7-DC22-486F-96A4-57041B211362Q37962995-4CF6CB3F-A1A2-4D4C-A39A-01E7A37AB47BQ38171876-CFC68BB1-639F-4797-B137-EA82AA709129Q38204497-C3A3D96F-61C9-402A-8D4D-0678FB8B4F34Q38699013-3F79D27B-FCC6-401D-A7A9-45B5BC5E4D4AQ39261867-C9FBD195-028D-4CE8-B517-E52C54BD3BA5Q41867178-B85F96D5-3B78-47C4-9B3E-1ED06049D8A6Q42554387-92882602-8ACE-4F2E-9576-506E56FCAB4DQ42905421-3E6D15BE-2297-47DF-8149-519676AA01E6Q43938609-20B354AD-3D98-490F-B1B8-52E6A2CDF16AQ45074229-8304BEBD-D9B7-4AB8-A1B4-BAD40AFC124CQ46490757-FF9A229A-984D-4699-9D0C-1021B0150155Q47973579-CD95D95B-470B-45F3-810A-F16D7B1BE342Q48559497-ADF7A4CA-CEB7-427B-B3F9-14866C02EED2Q48786659-F50C059B-CDBB-4ED1-BEF9-2E51962759CD
P2860
Differential regulation of alpha7 nicotinic receptor gene (CHRNA7) expression in schizophrenic smokers.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Differential regulation of alp ...... sion in schizophrenic smokers.
@ast
Differential regulation of alp ...... sion in schizophrenic smokers.
@en
type
label
Differential regulation of alp ...... sion in schizophrenic smokers.
@ast
Differential regulation of alp ...... sion in schizophrenic smokers.
@en
prefLabel
Differential regulation of alp ...... sion in schizophrenic smokers.
@ast
Differential regulation of alp ...... sion in schizophrenic smokers.
@en
P2093
P2860
P1476
Differential regulation of alp ...... sion in schizophrenic smokers.
@en
P2093
Judy Logel
Ralph Berger
Randal G Ross
Robert Freedman
Sharon Mexal
Sherry Leonard
P2860
P2888
P304
P356
10.1007/S12031-009-9233-4
P577
2009-08-13T00:00:00Z
P5875
P6179
1001715607